Carlo M. Croce
Affiliations: | Biochemistry | Ohio State University, Columbus, Columbus, OH |
Area:
BiochemistryWebsite:
https://medicine.osu.edu/cancer-biology-genetics/directory/faculty/croce-carlo/pages/index.aspxGoogle:
"Carlo M. Croce"Bio:
https://www.tandfonline.com/doi/pdf/10.4161/cc.1.6.256
DOI: 10.4161/cc.1.6.256
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Hilary Koprowski | research scientist | 1970-1974 | Wistar Institute of Anatomy and Biology (ID Tree) |
Children
Sign in to add trainee| Gianpiero Di Leva | grad student | 2009 | |
| Taewan Kim | grad student | 2007-2011 | Ohio State |
| Sung-Suk Suh | grad student | 2012 | Ohio State |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rampioni Vinciguerra GL, Capece M, Reggiani Bonetti L, et al. (2024) Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma. Signal Transduction and Targeted Therapy. 9: 31 |
| Cataldo A, Cheung DG, Hagan JP, et al. (2023) Genetic Loss of miR-205 Causes Increased Mammary Gland Development. Non-Coding Rna. 10 |
| Ng A, Lovat F, Shih AJ, et al. (2023) Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state. Proceedings of the National Academy of Sciences of the United States of America. 120: e2308658120 |
| Kim T, Croce CM. (2023) MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Experimental & Molecular Medicine |
| Fong LY, Huebner K, Jing R, et al. (2023) Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220334120 |
| Garofalo M, Di Leva G, Romano G, et al. (2022) Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell |
| Pichiorri F, Suh SS, Rocci A, et al. (2022) Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell |
| Pichiorri F, Suh SS, Rocci A, et al. (2022) Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell |
| Garofalo M, Romano G, Di Leva G, et al. (2022) Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nature Medicine |
| Garofalo M, Jeon YJ, Nuovo GJ, et al. (2022) Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. Plos One. 17: e0267628 |